Mammoth Biosciences Raises $195 Million, Vaulting Its Crispr Tech To Unicorn Status

Investors are betting the protein toolbox of the four-year-old startup can solve one of gene therapy ’s trickiest problems: getting treatments into the patient’s body.

Source: Forbes.com Healthcare News - September 9, 2021 Category: Pharmaceuticals Authors: Katie Jennings, Forbes Staff Tags: Healthcare /healthcare Innovation /innovation Science /science Venture Capital /venture-capital Editors' Pick editors-pick Coronavirus Source Type: news